@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .

<https://lod.nal.usda.gov/naltv#Definition>
  a owl:Class ;
  rdfs:label "Concept definition"@en .

nalt:34632_def
  a <https://lod.nal.usda.gov/naltv#Definition> ;
  rdf:value "Fenómenos y farmacéutica de compuestos que inhiben la función de agonistas (agonismo de fármacos) y agonistas inversos (agonismo inverso de fármacos) de un receptor determinado. Por sí mismos los antagonistas no producen ningún efecto en un receptor y se dice que carecen de eficacia y actividad intrínseca."@es, "Phenomena and pharmaceutics of compounds that inhibit the function of agonists (drug agonism) and inverse agonists ( drug inverse agonism) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy."@en ;
  dc:source "Medical Subject Headings 2016" .

nalt:34632 skos:definition nalt:34632_def .